Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Poland
  4. Warsaw Stock Exchange
  5. Mabion S.A.
  6. News
  7. Summary
    MAB   PLMBION00016

MABION S.A.

(MAB)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Mabion S.A. Reports Earnings Results for the Full Year Ended December 31, 2020

04/30/2021 | 04:52pm EST

Mabion S.A. Announced earnings results for the full year ended December 31, 2020. For the full year, the company announced operating loss was PLN 54.653 million compared to PLN 63.272 million a year ago. Net loss was PLN 55.772 million compared to PLN 63.738 million a year ago.


© S&P Capital IQ 2021
All news about MABION S.A.
11/29Mabion S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended Septem..
CI
09/20MABION S.A.(WSE : MAB) added to S&P Global BMI Index
CI
09/16Mabion S.A. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
05/20Big pharma and private equity seek healthy returns in Europe's east
RE
05/14MABION Announces Executive Changes
CI
04/30Mabion S.A. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
04/30Mabion S.A. Auditor Raises 'Going Concern' Doubt
CI
03/04Polish Biotech Mabion Enters Deal To Manufacture Novavax COVID-19 Jab
MT
03/03Mabion Biotech Signs Deal with Novavax on Covid-19 Vaccine Technology Transfer
CI
2020Mabion S.A. Reports Earnings Results for the Third Quarter Ended September 30, 2020
CI
More news
Financials
Sales 2021 11,3 M 2,76 M 2,76 M
Net income 2021 -59,0 M -14,5 M -14,5 M
Net Debt 2021 20,8 M 5,11 M 5,11 M
P/E ratio 2021 -20,7x
Yield 2021 -
Capitalization 1 230 M 302 M 302 M
EV / Sales 2021 111x
EV / Sales 2022 4,82x
Nbr of Employees 213
Free-Float 63,7%
Chart MABION S.A.
Duration : Period :
Mabion S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MABION S.A.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 2
Last Close Price 76,10 PLN
Average target price 68,50 PLN
Spread / Average Target -9,99%
EPS Revisions
Managers and Directors
Krzysztof Kaczmarczyk President-Management Board & CEO
Grzegorz Mariusz Grabowicz Chief Financial Officer
Robert Leszek Konski Chairman-Supervisory Board
Slawomir Jaros Chief Operating & Scientific Officer
David John James Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
MABION S.A.266.75%302
GILEAD SCIENCES, INC.19.65%87 443
BIONTECH SE258.12%70 510
REGENERON PHARMACEUTICALS35.38%68 384
WUXI APPTEC CO., LTD.24.26%64 686
VERTEX PHARMACEUTICALS-12.58%52 531